Riskpilot← Back to searchSign inGet full accessIrtaikysp AE AB
ABActiveOrg 5591522791SundsvallMedical specialists activities · NACE 8622Est. 20180 employees
Revenue 2025
SEK 710K
+15% vs 2024
EBITDA margin
38.3%
+156% vs 2024
Equity ratio
48.3%
Financial strength
Net profit 2025
SEK 219K
+145% vs 2024
| Revenue | SEK 710K | +15% |
| EBITDA | SEK 272K | +156% |
| Net profit | SEK 219K | +145% |
| Total assets | SEK 556K | +72% |
| Equity | SEK 269K | +92% |
| Employees | 0 | — |
Legal name
Irtaikysp AE AB
Org number
5591522791
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
13 mars 2018
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-08-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamoten suppleanten Firman tecknas ensam av externa firmatecknaren
Company purpose
Bolaget skall bedriva konsultationer inom företags organisation, handel med aktier och värdepapper samt därmed förenlig verksamhet.
Address
Sundsvall
Email
lars.svedin@contrado.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 566 | 1 212 | 1 001 | 617 | 710 |
| Staff expenses | — | −642 | −651 | −482 | −328 |
| EBITDA | 165 | 448 | 361 | 106 | 272 |
| Depreciation & amort. | −57 | −57 | −29 | — | — |
| EBIT | 108 | 391 | 332 | 106 | 272 |
| Net financials | −10 | −9 | 1 | 5 | 3 |
| Profit before tax | 98 | 382 | 333 | 112 | 275 |
| Tax | −30 | −79 | −69 | −23 | −56 |
| Net profit | 68 | 303 | 264 | 89 | 219 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 464 | 819 | 539 | 322 | 556 |
| Equity | 158 | 361 | 314 | 140 | 269 |
| Long-term debt | 144 | 0 | — | — | — |
| Short-term debt | 162 | 458 | 225 | 182 | 287 |
| Total debt | 306 | 458 | 225 | 182 | 287 |
EBITDA margin
38.3%
This company
15.8%
Market median
+142% vs market
20212025
Equity ratio
48.3%
This company
38.2%
Market median
+26% vs market
20212025
Return on equity
81.3%
This company
18.4%
Market median
+342% vs market
20212025
Net profit margin
30.8%
This company
8.1%
Market median
+280% vs market
20212025
Asset turnover
1.28×
This company
1.12×
Market median
+14% vs market
20212025
Debt / equity
1.07×
This company
0.62×
Market median
-73% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-09-01 – 2025-08-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-09-01 – 2024-08-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-09-01 – 2023-08-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-09-01 – 2022-08-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-09-01 – 2021-08-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
GS External Signatory | External Signatory | 2025 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2025 | |
| Deputy Board Member | 2025 | |
| Former (2) | ||
| Deputy Board Member | 2022 – 2025 | |
| Board of Directors | 2022 – 2025 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Irtaikysp AE AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Gun Sigrid Elisabeth Granlöf | External Signatory | 0 companies |
| Markus Sebastian Cederljung | Deputy Board Member | 0 companies |
| Eija Hannele Antonilli | Board of Directors | 0 companies |
| Lars Wolger Svedin | Board of Directors | 0 companies |
| Per Anton Wilhelm Uhlin | Deputy Board Member | 0 companies |